• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Sept. 23

    Beckman Coulter Helping Labs Comply With Annex 1 Regulation

    FDA Clears MeMed BV Direct From Whole Blood

    Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability

    EndoTheia Announces Positive Study Results for Endoscopic Surgery Device
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    LEMO USA Inc.

    Medbio LLC

    NDH Medical Inc.

    JBC Technologies

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    LEMO USA Inc.

    Medbio LLC

    NDH Medical Inc.

    JBC Technologies

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Abbott's Infinity Deep Brain Stimulation System Gains MR-Conditional Labeling

    New Informity tool helps simplify the Infinity DBS system programming process for physicians.

    Abbott
    Abbott's Infinity DBS system with directional leads is designed to direct stimulation toward targeted areas of the brain to maximize patient outcomes and limit side effects. Image courtesy of Abbott.
    Abbott Laboratories08.06.18
    Parkinson's disease and essential tremor patients can now benefit from upgraded functionality with Abbott's Infinity DBS system. Abbott announced U.S. Food and Drug Administration (FDA) approval for an over-the-air software upgrade for all currently implanted Infinity DBS systems that delivers magnetic resonance (MR)-conditional labeling and innovative features. This life-changing technology from Abbott helps patients with progressive diseases live better.
     
    Prior to the latest Abbott approval, people new to deep brain stimulation (DBS) therapy or those living with older systems from other manufacturers may have experienced barriers in accessing the most advanced DBS therapy options because of the potential need for an MRI in the future. With its updated labeling, Abbott has addressed this challenge with the Infinity DBS system's improved therapy platform—the first and only FDA-approved MR-conditional directional DBS system.
     
    "With this software upgrade, Abbott delivers on a promise to develop powerful features that strengthen the Infinity DBS system's already patient-centric platform, which uses familiar Apple technology and frees the patient from recharging their device," said Binith Cheeran, M.D., medical director of movement disorders at Abbott. "We are committed to continued innovation in neuromodulation, developing ongoing advancements and efficiencies for physicians and, most importantly, helping thousands of people who are battling movement disorders live fuller lives."
     
    This new approval allows existing implanted Infinity DBS systems to be upgraded via secure Bluetooth wireless technology without the need for surgery, giving full-body MRI conditional labeling to the entire Infinity DBS system, along with the suite of system upgrades.
     
    "Today's announcement of the newly released MRI-compatibility of the Infinity DBS system reflects Abbott's continued commitment to patient-centric, cutting-edge care—where the patient's options are expanded by the therapy instead of limited by it," said Brian Kopell, M.D., a neurosurgeon and director of the Center for Neuromodulation at Mount Sinai Health System in New York City.
     
    Parkinson's disease and essential tremor are neurologic conditions known as movement disorders, which are caused by a communication breakdown throughout the central nervous system. This can result in a debilitating loss of muscle control, involuntary movement and reduced coordination. At present there are no proven cures for movement disorders. Treatment options like Abbott's DBS system focus on alleviating symptoms to improve quality of life.
     
    Abbott's Infinity DBS system with directional leads is designed to direct stimulation toward targeted areas of the brain to maximize patient outcomes and limit side effects. The platform's future-ready technology is built with the ability to significantly upgrade the capabilities and new therapy features of the Infinity DBS system through simple, over-the-air updates.
     
    Abbott's Infinity DBS system is the world's first and only DBS system operating on an iOS software platform with Bluetooth wireless technology. Clinicians can streamline the programming process with an iPad mini device using Abbott's new Informity Programming Software to become more efficient in their practice and achieve optimal outcomes with directional leads. Patients can discreetly manage their symptoms with their Infinity DBS System iPod touch controller.
     
    Data continues to show that patients gravitate toward medical devices that are intuitive and low maintenance, such as with the Infinity DBS system's dual channel recharge-free device. Using an approach with patients at the center of their therapy experience, Abbott's neuromodulation portfolio is driven by science, data and patient input to help people suffering from movement disorders feel as normal as possible.
     
    "Our patients and our clinical team are seeing clear clinical benefits with Abbott's directional lead DBS therapy," said Craig van Horne, M.D., Ph.D., director of the Deep Brain Stimulator Center at the University of Kentucky's Neuroscience Institute. "The combination of directional lead therapy, MRI capability and simplicity in optimized programming could lead to a new standard of care for DBS therapy."
     
    Abbott's Infinity DBS system is also CE Mark approved and has been used in nearly 30 countries, most recently in Russia, Saudi Arabia, and Taiwan. 
    Related Searches
    • patient
    • ce mark
    • technology
    • deep brain stimulation
    Related Knowledge Center
    • Neurological
    Suggested For You
    FDA OKs NeuroOne FDA OKs NeuroOne's Evo sEEG Electrode
    Aleva Neurotherapeutics Recruits First Patient Into PMCF Study Aleva Neurotherapeutics Recruits First Patient Into PMCF Study
    FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients
    Avanos Medical Fined $22M for MicroCool Surgical Gown Misbranding Avanos Medical Fined $22M for MicroCool Surgical Gown Misbranding
    RSIP Vision Offers Real-Time Surgical Workflow Recognition for Robotic Surgery RSIP Vision Offers Real-Time Surgical Workflow Recognition for Robotic Surgery
    FDA Approves Medtronic FDA Approves Medtronic's SenSight Directional Lead System for DBS
    Encora Encora's Tremor Reducing Wristband Gains Breakthrough Status
    Jabil Healthcare, E3D Collaborate on Drug Delivery Device Tech Jabil Healthcare, E3D Collaborate on Drug Delivery Device Tech
    Abbott Releases NeuroSphere Virtual Clinic for Remote Neuromodulation Care Abbott Releases NeuroSphere Virtual Clinic for Remote Neuromodulation Care
    Medtronic Receives FDA Approval for Expanded MRI Labeling Medtronic Receives FDA Approval for Expanded MRI Labeling
    Boston Scientific Boston Scientific's Vercise Genus DBS Earns FDA Approval
    Expediting Time to Market—A Medtech Makers Q&A Expediting Time to Market—A Medtech Makers Q&A
    Boston Scientific Launches Vercise Genus DBS System In Europe Boston Scientific Launches Vercise Genus DBS System In Europe
    FDA OKs B. Braun FDA OKs B. Braun's SpaceStation MRI
    Scientists Suggest Device to Make Breast MRI More Effective Scientists Suggest Device to Make Breast MRI More Effective

    Related Breaking News

    • Neurological | Patient Monitoring
      FDA OKs NeuroOne

      FDA OKs NeuroOne's Evo sEEG Electrode

      Company's second FDA 510(k) clearance received.
      PR Newswire 09.08.21

    • Aleva Neurotherapeutics Recruits First Patient Into PMCF Study

      Aleva Neurotherapeutics Recruits First Patient Into PMCF Study

      Study aims to demonstrate improved outcomes with Aleva´s directSTIM Directional Deep Brain Stimulation system.
      Globe Newswire 09.01.21

    • Neurological
      FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients

      FDA OKs BrainsWay Deep TMS to Reduce Anxiety in Depressed Patients

      Expanded depression indication further demonstrates company’s leadership position.
      GlobeNewswire 08.19.21


    • Avanos Medical Fined $22M for MicroCool Surgical Gown Misbranding

      Avanos Medical Fined $22M for MicroCool Surgical Gown Misbranding

      Gowns were falsely labeled as providing the highest level of protection against fluid and virus penetration.
      U.S. Department of Justice 07.12.21

    • Surgical
      RSIP Vision Offers Real-Time Surgical Workflow Recognition for Robotic Surgery

      RSIP Vision Offers Real-Time Surgical Workflow Recognition for Robotic Surgery

      The module automatically tracks and identifies surgical steps during procedures, providing the basis for intraoperative clinical decision support systems.
      RSIP Vision 06.17.21

    Loading, Please Wait..

    Trending
    • A New Approach To Post-Market Surveillance
    • Medtronic Obtains EU Nod For Simplera CGM
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • SteriTek Opens New E-Beam/X-Ray Sterilization Facility Near Dallas
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • MPO's Most-Read Stories This Week—Sept. 23
    • Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    • FDA Clears MeMed BV Direct From Whole Blood
    • Biostrap Debuts Tool to Measure Stress Resilience, Heart Rate Variability
    • EndoTheia Announces Positive Study Results for Endoscopic Surgery Device
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Releases Sustainability Report for Omega-3s Industry
    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Coatings World

    Latest Breaking News From Coatings World

    ACS Reports Chameleon Inspired Building Coating
    Substrate Wetting Agent Available from BRB International
    Nouryon Manufacturing Network Transitions to 100% Electricity From Renewable Sources in Brazil
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 23
    Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    FDA Clears MeMed BV Direct From Whole Blood
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Eftilagimod Cleared for Clinical Trial Use in the UK
    Veranova Names William Sanders Global VP of Chemical Development Ops
    Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Hailey Bieber's Rhode Expands Into Makeup
    Avon Enters Retail Partnership with Superdrug
    IT Award Winners Announced at MakeUp in NY
    Happi

    Latest Breaking News From Happi

    Jared Leto Ends Skin Care Line Twentynine Palms
    Ideal Image Offers FDA-Approved Alternative to Botox
    Nulastin Unveils Hair Growth Outcomes from Pair of Studies
    Ink World

    Latest Breaking News From Ink World

    Cooper Watson Acquires Tower Products
    The Durst Group Awarded Eight 2023 PRINTING United Alliance Pinnacle Awards
    Weekly Recap: Wikoff Color, HP, INX VC Top This Week’s Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PRX Market debuts, Tower Products acquired and more
    Flexo Wash to exhibit at FTA Fall Technical Conference
    Recyclable, deinkable stand-up pouch wins Gold in Germany
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 23
    Anika Releases RevoMotion Reverse Shoulder Arthroplasty System
    Exactech's Activit-E Polyethylene OK'ed for Vantage Total Ankle
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HID to Showcase Future-Proof Solutions at GITEX 2023
    Weekly Recap: Mergers and Acquisitions, IEC’s IME Standards Top This Week’s Stories
    EU-Funded Collaboration Hub Aims to Mainstream Printed Electronics

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login